An estimate of the worldwide prevalence and direct costs of dementia in 2003

Dementia and Geriatric Cognitive Disorders

Volumn 21, Issue 3, 2006, Pages 175-181

  Wimo, A ^a,b   Jonsson, L ^a   Winblad, B ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HC Harmånger ^*  (Sweden)

Author keywords

Cost of illness; Worldwide direct costs; Worldwide prevalence

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST OF ILLNESS; DEMENTIA; DEVELOPING COUNTRY; ECONOMIC ASPECT; ECONOMIC EVALUATION; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STATISTICAL MODEL;

COST OF ILLNESS; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; DEMENTIA; DEVELOPED COUNTRIES; ECONOMICS; HEALTH EXPENDITURES; HUMANS; INCIDENCE; POPULATION DYNAMICS; WORLD HEALTH;

EID: 32044447659     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000090733     Document Type: Article

References (36)

1. Schneider EL, Guralnik JM: The aging of America. Impact on health care costs. JAMA 1990;263:2335-2340.
2. Rice DP, Fox PJ, Max W, Webber PA, Lindeman DA, Hauck WW, et al: The economic burden of Alzheimer's disease care. Health Aff (Millwood) 1993;12:164-176.
3. Jonsson B, Jonsson L, Wimo A: Cost of dementia; in May M, Sartorius N (eds): Dementia. WPA Series Evidence and Experience in Psychiatry. London, Wiley & Sons, 2000, pp 335-363.
4. Wimo A, Winblad B, Aguero Torres H, von Strauss E: The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord 2003;17:63-67.
5. Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J: Cost of disorders of the brain in Europe. Eur J Neurol 2005;12(suppl 1):1-27.
6. Jacobzone S, Cambois E, Chaplain E, Robine J: Long term care services to older people, a perspective on future trends: the impact of an improved health of older persons. Report No AWP 4.2. Paris, OECD, 1998.
7. Fratiglioni L, Rocca WA: Epidemiology of dementia; in Boller F, Cappa SF (eds): Handbook of Neuropsychology, ed 2. Amsterdam, Elsevier, 2001, pp 193-215.
8. UN: World population prospects: The 1998 revision. World population 1950-2050. New York, United Nations, 1998.
9. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, et al: Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000;54(suppl 5):S4-S9.
10. Hofman A, Rocca WA, Brayne C, Breteler MM, Clarke M, Cooper B, et al: The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. Int J Epidemiol 1991;20:736-748.
11. Rice DP, Hodgson TA, Kopstein AN: The economic costs of illness: a replication and update. Health Financing Rev 1985;7:61-80.
12. Siegel JE, Torrance GW, Russell LB, Luce BR, Weinstein MC, Gold MR: Guidelines for pharmacoeconomic studies. Recommendations from the panel on cost effectiveness in health and medicine. Panel on cost Effectiveness in Health and Medicine. Pharmacoeconomics 1997;11:159-168.
13. World Economic Outlook: International Monetary Fund. http://www.imf.org/ external/pubs/ft/weo/2004/02/data/index.htm.
14. World bank classification of economies, 2005. http://www.wordlbank.org/ data/countryclass/classgroups.htm.
15. Håkansson S: Different ways of organizing and financing health care; in Wimo A, Jönsson B, Karlsson G, Winblad B (eds): Health Economics of Dementia. London, Wiley & Sons, 1998, pp 67-97.
16. Gerdtham UG, Lothgren M: On stationarity and cointegration of international health expenditure and GDP. J Health Econ 2000;19:461-475.
17. International Monetary Fund: World Economic Outlook Database, 2004. http://www.imf.org/external/pubs/ft/weo/2004/02/data/index.htm#countryinfo.
18. International Labour Organization: Laborsta Internet, 2004. http://laborsta.ilo.org/.
19. Ernst RL, Hay JW: The US economic and social costs of Alzheimer's disease revisited. Am J Public Health 1994;84:1261-1264.
20. Manton KG, Corder LS, Clark R: Estimates and projections of dementia-related service expenditures; in Suzman R, Singer B, Manton KG (eds): Forecasting the Health of the Oldest Old. New York, Springer, 1993, pp 207-238.
21. Ostbye T, Crosse E: Net economic costs of dementia in Canada. CMAJ 1994;151:1457-1464.
22. Hux MJ, O'Brien BJ, Iskedjian M, Goeree R, Gagnon M, Gauthier S: Relation between severity of Alzheimer's disease and costs of caring. CMAJ 1998;159:457-465.
23. McNamee P, Bond J, Buck D: Costs of dementia in England and Wales in the 21st century. Br J Psychiatry 2001;179:261-266.
24. Smith KA, Shah A: The prevalence and costs of psychiatric disorders and learning disabilities. Br J Psychiatry 1995;166:9-18.
25. Holmes J, Pugner K, Phillips R, Dempsey G, Cayton H: Managing Alzheimer's disease: the cost of care per patient. Br J Health Care Management 1998;4:332-337.
26. Wimo A, Karlsson G, Sandman PO, Corder L, Winblad B: Cost of illness due to dementia in Sweden. Int J Geriatr Psychiatry 1997;12:857-861.
27. Schulenberg J, Schulenberg I: Cost of treatment and cost of care for Alzheimer's disease in Germany; in Wimo A, Jonsson B, Karlsson G, Winblad B (eds): The Health Economics of Dementia. London, Wiley & Sons, 1998, pp 217-230.
28. Kronborg Andersen C, Sogaard J, Hansen E, Kragh-Sorensen A, Hastrup L, Andersen J, et al: The cost of dementia in Denmark: the Odense Study. Dement Geriatr Cogn Disord 1999;10:295-304.
29. Cavallo MC, Fattore G: The economic and social burden of Alzheimer disease on families in the Lombardy region of Italy. Alzheimer Dis Assoc Disord 1997;11:184-190.
30. Koopmanschap MA, Polder JJ, Meerding WJ, Bonneux L, van der Maas PJ: Costs of dementia in the Netherlands; in Wimo A, Jonsson B, Karlsson G, Winblad B (eds): The Health Economics of Dementia. London, Wiley & Sons, 1998, pp 207-216.
31. O'Shea E, O'Reilly S: The economic and social cost of dementia in Ireland. Int J Geriatr Psychiatry 2000;15:208-218.
32. WHO: World Health report, 2004. www.who.int/whr/2004/annex/topic/annex3. xls.
33. Mathers C, Stein C, Ma Fat D, Rao C, Inoue M, Tomijima N, et al: Global burden of disease 2000. Version 2: methods and results. Global Programme on Evidence for Health Policy Discussion Paper No 50. Geneva, WHO, 2002.
34. Prince M: Care arrangements for people with dementia in developing countries. Int J Geriatr Psychiatry 2004;19:170-177.
35. Kabir ZN, Szebehely M, Tishelman C: Support in old age in the changing society of Bangladesh. Ageing Soc 2002;22:615-636.
36. Logminiene Z, Norkus A, Valius L: Direct and indirect diabetes costs in the world. Medicina (Kaunas) 2004;40:16-26.